According to a new team-up between Eisai and Pokémon, when it comes to healthy sleep habits, people of all ages have gotta ...
Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. | Eli Lilly—which has already staged multiple efforts in ...
During a quarterly conference call, executives from Legend Biotech showed little concern for a new threat to its lone commercial product, multiple myeloma CAR-T Carvykti. | During a quarterly ...
Lilly’s Japan outlay comes on the heels of a major $3 billion investment in the company’s manufacturing operations in China, where the pharma giant has pledged to set up local production for oral ...
It’s out with the old, in with the new at the FDA as the agency is unveiling a new adverse events monitoring system that joins several reporting systems into one unified platform, an effort that’s | ...
Yet, despite the “stormy waters,” global sales of orphan drugs are projected to exceed $400 billion by 2032, according to a new report by Evaluate.
Twelve months ago, drugmakers came roaring into 2025, fueled by a massive year of growth that peaked in the fourth quarter of ...
Veeva is paying approximately $100 million to acquire Ostro, according to this week’s announcement, comprising a combination ...
After strutting its stuff against blockbusters in three head-to-head psoriasis trials, UCB’s Bimzelx has conquered another powerhouse product—AbbVie’s Skyrizi—in psoriatic arthritis (PsA). | After ...
Skyhawk Therapeutics has named Aaron Deves as chief commercial officer, securing the expertise of an executive who oversaw ...
About five months after U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. | About five months after U.S. Health Secretary Robert F. Kennedy Jr. touted leucovorin as “an ...
As AstraZeneca kicks off the third year of its hockey-themed “Get Body Checked Against Cancer” campaign, the pharma has tapped two celebs known for their work both on and off the ice. | As AstraZeneca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results